GlycoMimetics, Inc. (GLYC) CEO Harout Semerjian on Q2 2022 Results - Earnings Call Transcript [Seeking Alpha]
GlycoMimetics, Inc. (GLYC)
Last glycomimetics, inc. earnings: 5/1 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.glycomimetics.com/investor-relations
Company Research
Source: Seeking Alpha
GlycoMimetics, Inc. (NASDAQ:GLYCCompany ParticipantsChristian Dinneen-Long - Company CounselHarout Semerjian - Chief Executive OfficerBrian Hahn - Chief Financial OfficerBruce Johnson - Chief Commercial OfficerConference Call ParticipantsBoris Peaker - Cowen and CompanyRoger Song - JefferiesSteve Bersey - H.C. WainwrightOperatorGood morning, and thank you for joining the GlycoMimetics Q2 2022 earnings call. At this time all participants are in listen only mode. Following management's remarks, we will hold a question-and-answer session. [Operator Instructions]I would now like to turn the call over to Christian Dinneen-Long company counsel at GlycoMimetics. Please go ahead.Good morning. Today we will review our business updates and financial results for the quarter ended June 30 2022. The press release we issued this morning is available on the company's website@glycomimetics.com under the Investors tab.This call is being recorded. A dial in phone replay will be available for 24 hours a
Show less
Read more
Impact Snapshot
Event Time:
GLYC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GLYC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GLYC alerts
High impacting GlycoMimetics, Inc. news events
Weekly update
A roundup of the hottest topics
GLYC
News
- Uproleselan's failed Phase III AML trial shakes up GlycoMimetics' future [Yahoo! Finance]Yahoo! Finance
- GlycoMimetics, Inc. (NASDAQ: GLYC) was downgraded by analysts at Capital One Financial Co. from an "overweight" rating to an "equal weight" rating.MarketBeat
- GlycoMimetics reports data from Phase III AML treatment trial [Yahoo! Finance]Yahoo! Finance
- We're Keeping An Eye On GlycoMimetics' (NASDAQ:GLYC) Cash Burn Rate [Yahoo! Finance]Yahoo! Finance
- GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024Business Wire
GLYC
Earnings
- 5/9/24 - Miss
GLYC
Analyst Actions
- 3/27/24 - HC Wainwright
GLYC
Sec Filings
- 5/9/24 - Form 10-Q
- 5/8/24 - Form SC
- 5/6/24 - Form 8-K
- GLYC's page on the SEC website